Dapagena 10mg (Dapagliflozin Monohydrate and Lactose Mixture)
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Terra Genetex Co., Ltd.
MFDS item code 202005360 · Approved 2020.07.23
This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medicine helps control blood sugar levels in patients with type 2 diabetes. It is used adjunctively when undergoing dietary and exercise therapy and can be used alone or in combination with other medications. It is particularly administered to patients with type 2 diabetes who either have cardiovascular diseases or risk factors, especially if their blood sugar is not sufficiently controlled. For information on the impact on cardiovascular events, please refer to specialized precaution information. This medicine is used to effectively improve blood sugar control.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10 mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue, such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received diabetes medication, the recommended initial dose of this medicine when administered in combination with metformin is 5 mg once daily or 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medicine should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should not be given to patients with type 1 diabetes or diabetic ketoacidosis. Patients with genetic lactose intolerance, such as galactose intolerance or lactase deficiency, may be at risk when taking this medicine. Patients undergoing renal dialysis should also refrain from using this medicine. In patients with low fluid volume or impaired renal function, this medicine should be used with caution, As it can lead to lowering blood pressure or worsening kidney function, it is essential to thoroughly check fluid status and kidney function before and during administration. Especially elderly patients or patients on diuretics are at a higher risk of hypotension and require caution. This medicine contains Yellow No. 4 and Yellow No. 5 dyes, so patients with a history of allergy to these ingredients should be careful. Infection symptoms may occur, such as genital and urinary tract infections, so immediate consultation with medical personnel is recommended if any symptoms of infection emerge. Also, hypoglycemic symptoms may arise, thus dose adjustments may be necessary if taken alongside insulin or sulfonylureas to reduce the risk of hypoglycemia. Symptoms such as dehydration, hypotension, dry mouth may occur due to decreased fluid volume, thus adequate hydration and symptom monitoring are crucial. Diabetic ketoacidosis, a severe metabolic disturbance, may occur rarely, and this symptom can arise even when blood sugar levels are not elevated, Thus, immediate medical attention should be sought if experiencing symptoms like nausea, vomiting, abdominal pain, or difficulty breathing. This medicine's effectiveness can vary based on kidney function, hence patients with severely impaired kidney function may experience reduced blood sugar control effects. Women who are pregnant or planning to become pregnant should avoid using this medicine, And breastfeeding women should also avoid taking this medicine for safety reasons. There is no specific antidote for overdosing, so appropriate treatment should be provided according to symptoms, And if an overdose is suspected, immediate consultation with medical personnel is necessary. While taking this medicine, caution should be exercised when driving or operating machinery due to the potential for hypoglycemic side effects, Especially when combined with insulin or sulfonylureas, more caution is needed. Finally, the safety and efficacy in children have not been established, so it is not used in pediatric patients.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar itching, genital itching, increased hematocrit, decreased creatinine clearance at the start of treatment, dyslipidemia, elevated serum creatinine at the start of treatment, increased serum urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, brain hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulitis, gastric distension, frequent bowel movements, gastroenteritis, colon polyp, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic gastritis, gastrointestinal disorders, abdominal discomfort, abdominal pain, esophagitis, lower abdominal pain, upper abdominal pain, enteritis, gastric ulcer, urinary urgency, diabetic nephropathy, overactive bladder, microalbuminuria, exertional urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, urinary urgency, increased serum lactate, lymphocytopenia, weight gain, decreased appetite, acanthosis nigricans, hyperglycemia, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, periapical periodontitis, pneumonia, pulmonary tuberculosis, rhinitis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like syndrome, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, menstrual irregularity, genital edema, vulvar discomfort, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is important to maintain a storage temperature between 1°C and 30°C room temperature. By storing this way, the effectiveness of the medicine can be safely preserved.
Yellow, bi-convex, diamond-shaped film-coated tablet
28 tablets/PTP [(7 tablets/PTP x 4, 14 tablets/PTP x 2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Terra Genetex Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Sinil Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Dapagliflozin Anhydrous Lactose Mixture 15.27mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Dapagliflozin Anhydrous Lactose Mixture 7.635mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.